Edward C. Stites

Also affiliated with Smilow Cancer Hospital

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Cancer research is not correlated with driver gene mutation burdens”.

Cancer research is not correlated with driver gene mutation burdens

Med(2024)10.1016/j.medj.2024.05.013

N/A

0.165DataRank · unranked

2 citations

David Liarakos, Melinda Tong, Satoko Ito, Eugene Ke, George Goshua +2 more

The Interpretation of SARS-CoV-2 Diagnostic Tests

Med(2020)10.1016/j.medj.2020.08.001

N/A

0DataRank · unranked

55 citations

Craig B. Wilen, Edward C. Stites

Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors

Cell Communication and Signaling(2020)10.1186/s12964-020-00645-3

N/A

0DataRank · unranked

26 citations

Noah K. Schomburg, Kent L. Rossman, Edward C. Stites, Thomas McFall

Cancer gene mutation frequencies for the U.S. population

Nature Communications(2021)10.1038/s41467-021-26213-y

N/A

0DataRank · unranked

208 citations

Eugene Ke, Meraj Aziz, David Liarakos, Melinda Tong, Edward C. Stites +1 more

Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach

Cell Reports(2021)10.1016/j.celrep.2021.110096

N/A

0DataRank · unranked

28 citations

Edward C. Stites, Thomas McFall

KRAS-Mutated, Estrogen Receptor-Positive Low-Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery

The Oncologist(2021)10.1002/onco.13702

N/A

0DataRank · unranked

14 citations

Thomas McFall, Kenta Takahashi, Kasey Bamel, Sadakatsu Ikeda, Ramez N. Eskander +5 more

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

npj Precision Oncology(2022)10.1038/s41698-022-00329-w

N/A

0DataRank · unranked

19 citations

Michael Trogdon, Anita C. Guizar, John F. Langenheim, Laura Sisk-Hackworth, Edward C. Stites +1 more

Theoretical analysis reveals a role for RAF conformational autoinhibition in paradoxical activation

eLife(2023)10.7554/elife.82739

N/A

0DataRank · unranked

8 citations

Edward C. Stites, Gaurav Mendiratta

Computational Random Mutagenesis to Investigate RAS Mutant Signaling

Methods in molecular biology(2023)10.1007/978-1-0716-3008-2_15

N/A

0DataRank · unranked

1 citations

Edward C. Stites

Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation

npj Systems Biology and Applications(2024)10.1038/s41540-024-00400-1

N/A

0DataRank · unranked

4 citations

Kodye L. Abbott, Nadia Arang, Kathryn Lande, Navneet Kaur, Melinda Tong +4 more

Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer: Universal Germline vs Sequential Screening

Clinical Gastroenterology and Hepatology(2025)10.1016/j.cgh.2025.03.006

N/A

0DataRank · unranked

1 citations

Rosa M. Xicola, Manraj Singh, Kunal C. Potnis, Vinit Singh, Peter Gershkovich +6 more

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Nature Communications(2020)10.1038/s41467-020-18613-3

N/A

0DataRank · unranked

303 citations

Ki Hwan Kim, Hyo Jeong Lim, Amélie Boichard, Mina Nikanjam, Elizabeth Weihe +17 more

Mathematical modeling suggests 14-3-3 proteins modulate RAF paradoxical activation

PLoS Computational Biology(2025)10.1371/journal.pcbi.1013297

N/A

0DataRank · unranked

0 citations

Kodye L. Abbott, Yaocheng Li, Jingting Yu, Peter Carlip, Melinda Tong +6 more